Overview
Xiaojia Xu practices practicing medicine in Guangzhou, China.
Their clinical expertise encompasses Doxorubicin-Induced Cardiomyopathy, Cardiomyopathy Due to Anthracyclines, Chickenpox, and Hepatitis B.
They are actively involved in clinical research, co-authoring 19 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Xiaojia Xu
Is Xiaojia Xu a top-rated expert for Doxorubicin-Induced Cardiomyopathy?
MediFind is an objective health platform that identifies experts based on real-world data. Xiaojia Xu is classified as an Experienced expert for Doxorubicin-Induced Cardiomyopathy, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Xiaojia Xu participate in research or clinical trials?
Yes. Xiaojia Xu has published 19 articles and abstracts on conditions like Doxorubicin-Induced Cardiomyopathy. You can view a list of Xiaojia Xu's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Cardiomyopathy Due to Anthracyclines
- ChickenpoxXu isExperienced. Learn about Chickenpox.
- Doxorubicin-Induced Cardiomyopathy
- FluXu isExperienced. Learn about Flu.
- Hepatitis BXu isExperienced. Learn about Hepatitis B.
- Maturity Onset Diabetes of the Young